By Andrea Anderson

NEW YORK (GenomeWeb News) – A pair of studies appearing online in Nature Biotechnology yesterday highlight the value of targeted mass spectrometry-based pipelines for finding potential biomarkers and focusing in on those with clinical potential.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.